Ching Chi Hsu
Director/Board Member at Actherm Co. Ltd.
Profile
Ching Chi Hsu is currently a Director at Actherm Co. Ltd.
and Magnifica, Inc. He was formerly a Director & Spokesman at Easywell Biomedicals, Inc. He completed his undergraduate degree at Chinese Culture University.
Ching Chi Hsu active positions
| Companies | Position | Start |
|---|---|---|
| Actherm Co. Ltd. | Director/Board Member | - |
Magnifica, Inc.
 Magnifica, Inc. Pharmaceuticals: MajorHealth Technology Magnifica, Inc. is an international law and tax consultancy firm that specializes in the sports business. The private company is based in Cranbury, NJ. The company provides expert advice to sporting clubs and federations on new earnings opportunities and explore new business opportunities. The company specializes in intermediation and representing professional football players. The company offers their services to clients in various countries. | Director/Board Member | - |
Former positions of Ching Chi Hsu
| Companies | Position | End |
|---|---|---|
| EASYWELL BIOMEDICALS, INC. | Chief Executive Officer | - |
Training of Ching Chi Hsu
| Chinese Culture University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EASYWELL BIOMEDICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Actherm Co. Ltd. | |
Magnifica, Inc.
Magnifica, Inc. Pharmaceuticals: MajorHealth Technology Magnifica, Inc. is an international law and tax consultancy firm that specializes in the sports business. The private company is based in Cranbury, NJ. The company provides expert advice to sporting clubs and federations on new earnings opportunities and explore new business opportunities. The company specializes in intermediation and representing professional football players. The company offers their services to clients in various countries. | Health Technology |
- Stock Market
- Insiders
- Ching Chi Hsu
